Eli Lilly has filed a lawsuit against HRSA for allegedly obstructing its plan to modify drug discounts for hospitals under the federal 340B program. The program requires drugmakers to provide discounts to healthcare providers serving low-income populations.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing